Suppr超能文献

评估术前和术后 Karakiewicz 列线图在肾细胞癌中的准确性和泛化能力:一项多中心欧洲和美国研究的结果。

Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study.

机构信息

"S. Pio Da Pietrelcina" Hospital, Dept. of Urology, Vasto, Italy.

出版信息

BJU Int. 2013 Sep;112(5):578-84. doi: 10.1111/j.1464-410X.2012.11670.x. Epub 2013 Mar 7.

Abstract

OBJECTIVE

To assess the accuracy and generalizability of the pre- and postoperative Karakiewicz nomograms for predicting cancer-specific survival (CSS) in patients with renal cell carcinoma (RCC).

PATIENTS AND METHODS

This retrospective study included 3231 patients from European and US centres, who were treated by radical or partial nephrectomy for RCC between 1992 and 2010. Prognostic scores for each patient were calculated and the primary endpoint was CSS. Discriminating ability was assessed by Harrell's c-index for censored data. The 'validation by calibration' method proposed by Van Houwelingen was used for checking the calibration of covariate effects. Calibration was graphically explored.

RESULTS

Local and systemic symptoms were present in 23.2% and 9.1% of the patients, respectively. The median follow-up (FU) was 49 months. At the last FU, 408 cancer-related deaths were recorded, Kaplan-Meier estimates of CSS (with 95% confidence intervals [CIs]) at 5 and 10 years were 0.86 (0.84-0.87) and 0.77 (0.75-0.80), respectively. Both nomograms discriminated well. Stratified c-indices for CSS were 0.784 (95% CI 0.753-0.814) for the preoperative nomogram, and 0.842 (95% CI 0.816-0.867) for the postoperative one, with a significant difference between the two values (P < 0.001). The covariate-based predictions on our data for both nomograms were valid. The calibration plots showed no relevant departures from ideal predictions.

CONCLUSIONS

The results suggest that the postoperative Karakiewicz nomogram discriminates substantially better than the preoperative one. These nomogram-based predictions may be used as benchmark data for pretreatment and postoperative decision-making in patients at various stages of RCC.

摘要

目的

评估术前和术后 Karakiewicz 列线图预测肾细胞癌(RCC)患者癌症特异性生存(CSS)的准确性和泛化能力。

患者与方法

本回顾性研究纳入了 1992 年至 2010 年间在欧洲和美国中心接受根治性或部分肾切除术治疗的 3231 例 RCC 患者。为每位患者计算预后评分,主要终点为 CSS。使用删失数据的 Harrell c 指数评估判别能力。使用 Van Houwelingen 提出的“验证校准”方法检查协变量效应的校准。图形探索校准。

结果

分别有 23.2%和 9.1%的患者存在局部和全身症状。中位随访(FU)时间为 49 个月。在最后一次 FU 时,记录了 408 例癌症相关死亡事件,Kaplan-Meier 估计的 CSS(95%置信区间[CI])在 5 年和 10 年时分别为 0.86(0.84-0.87)和 0.77(0.75-0.80)。两个列线图均能很好地进行区分。CSS 的分层 c 指数分别为术前列线图的 0.784(95%CI 0.753-0.814)和术后列线图的 0.842(95%CI 0.816-0.867),两者之间存在显著差异(P<0.001)。对我们的数据进行基于协变量的预测,两种列线图都是有效的。校准图显示与理想预测没有明显偏差。

结论

结果表明,术后 Karakiewicz 列线图的区分能力明显优于术前列线图。这些基于列线图的预测可以作为 RCC 各阶段患者术前和术后决策的基准数据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验